Stay updated with breaking news from Hexvix Cysview. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces its participation in the congress, and two abstract presentations at the AUA...
Press release - Oslo, Norway, March 28, 2024: Photocure ASA, The Bladder Cancer Company, announces the publication of the study Racial Difference in Detection Rate of Bladder Cancer Using Blue Light...
/PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated today that...
Oslo, Norway, 8 November 2023 - Photocure ASA today reported Hexvix®/Cysview® revenues of NOK 107.3 million in the third quarter of 2023 , and an EBITDA of NOK 3.3 million for the company....
/PRNewswire/ -- Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 107.3 million in the third quarter of 2023 (Q3 2022: NOK 96.9 million),...